Recent News Gilead Sets Ambitious HIV Sales Targets Following Strong Market Performance For Yeztugo Gilead Sciences is positioning itself for a significant period of expansion within its core therapeutic area, signaling to investors that the pharmaceutical by Josh Weiner 3 hours ago